RESEARCH PAPER
Prevalence of hypertension in a sample of Polish population – baseline assessment from the prospective cohort ‘PONS’ study
More details
Hide details
1
Department of Internal Diseases, Wroclaw Medical University, Wroclaw, Poland
2
Department of Social Medicine, Wroclaw Medical University, Wroclaw, Poland
3
Department of Food Science and Dietetics, Wroclaw Medical University, Wroclaw, Poland
4
Department of Dietetics, Wroclaw Medical University, Wroclaw, Poland
5
Norwegian University of Science and Technology, Faculty of Medicine, Department of Public Health, University Medical Centre, Trondheim, Norway
6
Department of Cancer Epidemiology and Prevention, the Maria Skłodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland
7
European Health Inequalities Observatory, Institute of Rural Health, Lublin, Poland
Ann Agric Environ Med. 2011;18(2):260-264
KEYWORDS
ABSTRACT
Objective:
The aim of this cohort study was to evaluate the prevalence of hypertension and cardiovascular risk factors in the studied population.
Material and Methods:
Presented results are a part of the Polish-Norwegian Study (PONS) project. The study group consisted of 3,862 inhabitants of Świętokrzyskie Province aged 45-64 years (2,572 females and 1,290 males).
Results:
Prevalence, awareness and control of hypertension was evaluated in the studied population of 3,854 urban and rural inhabitants. Mean blood pressure in the whole studied population was 139.6/81.9 mmHg; of the studied population 61.7% were hypertensive. Hypertension was more prevalent in the studied males (70.63%) than in the females (57.24%). In both males and females, the older subgroups (55-64 y.o.) had significantly higher blood pressure than the younger subgroups (45-54). Education had a significant impact on the prevalence of hypertension, and the highest prevalence of hypertension was observed in the middle level educated groups of females and males. No significant difference was observed between rural and urban inhabitants. In both females and males, the prevalence of hypertension significantly decreased with level of education. Hypertension was well-controlled in only 13.8% of the subjects. More studied females than males achieved good control of blood pressure (14.09 vs. 12.7%), and better control of blood pressure was significantly more frequent in better those who were better educated. Hypertension was not diagnosed in 23.2% of studied population. Significantly, more males than females had undiagnosed hypertension (30.4 vs. 19.5%). No significant difference between rural and urban populations was observed. Interestingly, both in females and males, the better educated groups had more undiagnosed hypertension than those who were well-educated.
Conclusions:
The studied group had a high prevalence of hypertension (61.7%), which was less frequent and better controlled in the studied females than in the males. No significant difference was observed between the urban and rural populations. Level of education had significant impact on the prevalence of hypertension.
REFERENCES (27)
1.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of wordwide data. Lancet 2005;365:217-223.
2.
Wolf-Maier K, Cooper RS, Benegas JR, Giampaoli S, Hense HW, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003;289:2363-2369.
3.
Castelli WP. Epidemiology of coronary heart disease. Th e Framingham Study. Am J Med 1984;76:4-12.
4.
Lewington S, Clarke R, Qizilbash N, et al. Age specifi c relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
5.
Whelton PK. Epidemiology of hypertension. Lancet 1994;344:101- 106.
6.
Wojtyła A, Biliński P, Jaworska-Łuczak B. Regulatory strategies to ensure food and feed safety in Poland – update review. Ann Agric Environ Med 2010;17:215–220.
7.
Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
8.
Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. APROS Investigators. Role of echocardiography and carotid ultrasonography in stratifying risk in patient with essensial hypertension: the Assesmetn of Prognostic Risk Observational Survey. J Hypertens 2002;20:1307-1314.
9.
Kaplan GA, Keil JE. Socio-economic factors and cardiovascular disease: a review on the literature. Circulation 1993;88:1973-1988.
10.
Mancia G, Grasii G. Th e new European Society of Hypertension/ European Society of Cardiology [ESH/ESC] Guidelines. Th er Adv Cardiovasc Dis 2008;2:5-12.
11.
Gueyffi er F, Boutitie F, Boissel JP, Pocock S, Coope J, et al. Th e eff ect of antihypertensive drug treatment on cardiovascular outcomes in women and men: results from meta-analysis of individual patient data randomized controlled trials. Ann Intern Med 1997;126:761-767.
12.
Grassi G, Cifk ova R, Laurent S, Narkiewicz K, Redon J, et al. Blood pressure control and cardiovascular risk profi le in hypertensive patient from central and eastern European countries: results of BP-CARE study. Eur Heart J 2011;32:218-25.
13.
Zdrojewski T, Szpakowski P, Bandosz P, Pająk A, Więcek A, et al. Arterial hypertension in Poland 2002. J Hum Hypertens 2004;18:557- 62.
14.
Wągrowska H, Rywik S. Występowanie nadciśnienia tętniczego w populacji prawobrzeżnej Warszawy na podstawie badań Pol-MONICA. (Prevalence of hypertension in population of right-bank Warsaw. Th e results of the Pol-MONICA project). Wiad Lek 1990;43:47-55.
15.
Polakowska M, Piotrowski W, Włodarczyk P, Broda G, Rywik S. Program epidemiologiczny oceniający częstość nadciśnienia tętniczego w Polsce w populacji osób dorosłych- badanie PENT. Część I Charakterystyka częstości i stopień kontroli nadciśnienia tętniczego. (Epidemiological survey for assessment of hypertension prevalence in adult population of Poland – the PENT study. Part I: Prevalence and control of arterial hypertension). Nadciśnienie Tętnicze 2002;3:157-166.
16.
Zdrojewski T, Bandosz P, Gaciong Z, Wyrzykowski B. Rozpowszechnienie czynników ryzyka chorób układu sercowo-naczyniowego w Polsce w 2011 r. Zakres wieku 18-79 lat. NATPOL 2011. (Prevalence of cardiovascular risk factors in Poland in 2011. Population 18-79 y.o. NATPOL 2011 project). XV Międzynarodowy Kongres PTK, Wrocław 6-8 October 2011.
17.
Mancia G, Laurent S, Gabiti-Rosei E, Ambrosioni E, Burnier M, Caufi eld MJ, et al. Reappraisal of European Guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-58.
18.
Kannel WB. Blood pressure as the cardiovascular risk factor. JAMA 1996;275:1571-1576.
19.
Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases Part I: General Consideration, the Epidemiologic Transition, Risk factor, and Impact of Urbanization. Circulation 2001;104:2746- 2753.
20.
Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension : a systematic review. J Hypertens 2004;22:11- 9.
21.
Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health survey for England 2006. Hypertension 2009;53:480-486.
22.
Egan MB, Zhao Y, Axon RN. US trends in prevalence, awareness , treatment and control of hypertension 1988-2000. JAMA 2010;303:2043- 2050.
23.
Centers for Disease Control and Prevention [CDC]. Vital signs: prevalence, treatment and control of hypertension – United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 2011;4:103- 108.
24.
Ostchega Y, Hughes JP, Wright JD, McDowell MA, Luis T. Are demographic characteristics health care access and utilization and comorbid conditions associated with hypertension among US adults? Am J Hypertens 2008;21:159-165.
25.
Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005;294:466-472.
26.
He J, Muntner P, Chen J, Rocella EJ, Streiff er RH, Whelton PK. Factors associated with hypertension control in general population of the United States. Arch Intern Med 2002;162:1051-1058.
27.
Nilsson PM. Adverse social factors can predict hypertension – but how? Eur Heart J 2009;30:1305-1306.